NCT00617968View on ClinicalTrials.gov

GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

June 30, 2005

Conditions

Breast Neoplasms

Interventions

DRUG

DOCETAXEL

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00617968 - GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer | Biotech Hunter | Biotech Hunter